Free Trial

Candel Therapeutics (CADL) Earnings Date, Estimates & Call Transcripts

Candel Therapeutics logo
$5.82 -0.09 (-1.52%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$5.91 +0.09 (+1.53%)
As of 08/28/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Candel Therapeutics Earnings Summary

Candel Therapeutics issued Q2 2025 earnings on August 14, 2025, reporting an EPS of -$0.09, which beat analysts' consensus estimates of -$0.17 by $0.08. With a trailing EPS of -$0.69, Candel Therapeutics' earnings are expected to grow next year, from ($1.47) to ($1.15) per share.

Upcoming Q3
Earnings Date
Nov. 13Before Market OpensEstimated
Consensus EPS
(Aug. 14)
-$0.17
Actual EPS
(Aug. 14)
-$0.09 Beat By $0.08

Q2 2025 Earnings Resources

CADL Upcoming Earnings

Candel Therapeutics' next earnings date is estimated for Thursday, November 13, 2025, based on past reporting schedules.

Get Candel Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Candel Therapeutics and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CADL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CADL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Candel Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20252-$0.18-$0.15-$0.17
Q3 20252-$0.21-$0.16-$0.19
Q4 20252-$0.23-$0.17-$0.20

Candel Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/13/2025
(Estimated)
--------
8/14/2025Q2 2025-$0.17-$0.09+$0.08-$0.09--
5/13/2025Q1 2025-$0.24$0.13+$0.37$0.13--
3/13/2025Q4 2024-$0.23-$0.40 -$0.17-$0.40--
8/13/2024Q2 2024--$0.74--$0.74--
5/14/2024Q1 2024--$0.28--$0.28--
3/28/2024Q4 2023-$0.16-$0.38 -$0.22-$0.38--
11/9/2023Q3 2023-$0.19-$0.29 -$0.10-$0.29--

Candel Therapeutics Earnings - Frequently Asked Questions

Candel Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 13th, 2025 based off last year's report dates. Learn more on CADL's earnings history.

In the previous quarter, Candel Therapeutics (NASDAQ:CADL) reported ($0.09) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.17) by $0.08. Learn more on analysts' earnings estimate vs. CADL's actual earnings.

Candel Therapeutics (NASDAQ:CADL) has a recorded annual revenue of $120,000.00.

Candel Therapeutics (NASDAQ:CADL) has a recorded net income of -$55.18 million. CADL has generated -$0.69 earnings per share over the last four quarters.

Candel Therapeutics' earnings are expected to grow from ($1.47) per share to ($1.15) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CADL) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners